Bilibili Inc.BILINASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank36
5Y CAGR-27.0%
Year-over-Year Change
Year-over-year research & development expense growth
5Y CAGR
-27.0%/yr
Long-term compound
Percentile
P36
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 4.40% |
| Q2 2025 | 2.96% |
| Q1 2025 | -8.47% |
| Q4 2024 | 1.46% |
| Q3 2024 | 1.27% |
| Q2 2024 | -7.30% |
| Q1 2024 | -27.29% |
| Q4 2023 | 24.49% |
| Q3 2023 | 1.80% |
| Q2 2023 | 2.01% |
| Q1 2023 | -31.27% |
| Q4 2022 | 32.08% |
| Q3 2022 | -0.06% |
| Q2 2022 | 12.18% |
| Q1 2022 | 26.48% |
| Q4 2021 | 1.18% |
| Q3 2021 | 17.02% |
| Q2 2021 | 16.10% |
| Q1 2021 | 19.89% |
| Q4 2020 | 20.68% |
| Q3 2020 | 21.29% |
| Q2 2020 | 11.20% |
| Q1 2020 | 21.28% |
| Q4 2019 | -0.87% |
| Q3 2019 | 14.57% |
| Q2 2019 | 16.01% |
| Q1 2019 | 21.23% |
| Q4 2018 | 4.98% |
| Q3 2018 | 10.84% |
| Q2 2018 | 24.54% |
| Q1 2018 | 21.75% |
| Q4 2017 | 16.76% |
| Q3 2017 | 17.52% |
| Q2 2017 | 14.79% |
| Q1 2017 | 86.32% |
| Q4 2016 | 9.10% |
| Q3 2016 | 0.00% |